ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Clinical trial NCT06824363 · RECRUITING

Trial details

NCT number: NCT06824363
Sponsor: University of California, Irvine
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Malignant Solid Tumor Stomach Adenocarcinoma Esophageal Adenocarcinoma

Start date: 2026-05-25
Primary completion: 2027-01-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.